iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting

Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid development, especially use against hematologic malignancies. Clinical trials of NK cell-based adoptive transfer to treat relapsed or refractory malignancies have used peripheral blood, umbilical cord blood and plu...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldenson, Benjamin H., Hor, Pooja, Kaufman, Dan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851389/
https://www.ncbi.nlm.nih.gov/pubmed/35185932
http://dx.doi.org/10.3389/fimmu.2022.841107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851389/
https://www.ncbi.nlm.nih.gov/pubmed/35185932
http://dx.doi.org/10.3389/fimmu.2022.841107

Ejemplares similares